Pay in 4 interest-free payments of $7.21 Learn more
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17
Ethics declarations Funding This work was supported by the National Natural Science Foundation of China (82103475), Hebei Province Natural Science Foundation (H2023307028, H2024206056), the Medical Science Research Project of Hebei Provincial Health Commission (20240370), Hebei Province Medical Adaptation Technology Tracking Project (GZ2024002), and Hebei Province Government-Funded Clinical Medicine Excellent Talent Training Program (ZF2025013)
PMID: 25560952
What theyre saying: While the new generation of incretin therapies have been revolutionary for patients living with obesity, bimagrumab addresses a critical unmet need as a therapeutic that targets fat loss while building muscle mass. Versanis CEO Mark Pruzanski The solo act The drug: Altimmunes pemvidutide is a combination GLP-1 agonist and glucagon agonist
Your Awesome Photos and Videos Reviews 5 A great mask
Current Reviews in Clinical and Experimental Pharmacology, 16 (2), 162-167
Unsere hochgeschtzten Partner bestehen aus Branchenexperten, die unsere Werte und unser Engagement teilen
US$ 23.51
US$ 21.65
US$ 26.54
US$ 20.30
US$ 21.88
US$ 24.94
US$ 22.70
